CD274 and neoplasm: However, by enhancing tumor cell susceptibility to NK cell killing and by increasing tumor infiltration and activation of NK cells, the combination of radiation and cetuximab therapy triggers recruitment and activation of CD8+ T cells, priming an adaptive response to “cold” tumors and enabling durable tumor eradication when combined with anti–PD-L1 therapy.